Absolute Markets Insights (AMI) reports a robust growth forecast for the global urology surgical instruments market during the forecast period (2021 – 2029). In its newly released report, AMI anticipates that the market will grow at 7.8% owing to increasing investments towards enhancement of healthcare infrastructure. AMI reports that the market stood at a valuation of US$ 10.42 Bn in 2020. The purpose of urology surgeries is to treat a urologic disease or dysfunction of male or female urinary tract. The increasing geriatric population is one of the key factors aiding the growth of global urology surgical instruments market because geriatric suffer from urology problems very often. This age group are considered to be more prone to digestive disorders, incontinence, and many chronic conditions that require long-term care.
Access the Full Report @ https://www.absolutemarketsinsights.com/reports/Global-Urology-Surgical-Instruments-Market-2021—2029-912
The risks being faced by global medical sector due to China-originated coronavirus were unprecedented. There is an urgent need for alternative patient management tools such as telemedicine services that help clinicians to maintain necessary patient rapport with their healthcare provider. The use of telemedicine started to increase due to COVID-19 but it rapidly increased in various streams of medical sector which included urology sector. A study from China showed that patients with genitourinary malignancies could face even greater risk than their age matched cohort as cancer patients were noted to have higher risk and more severe outcomes compared to other patients. In September 2021, the data from two studies were presented at the American Urological Association meeting, which highlighted that COVID-19 patients experienced severe genitourinary symptoms during infection, along with new or worsening overactive bladder symptoms after recovery. Treatment for dialysis showcases positive growth prospects for global urology surgical instruments market growth. Dialysis treatment is considered important in the urology department as well as urology-related markets in many countries due to the increased demand for advanced dialysis products and improved facilities for end-stage renal disease (ESRD) treatment.
According to Absolute Markets Insights report, imaging systems & video hardware is estimated to be the fastest growing category in the application segment during the forecast period in the global urology surgical instruments market. However, the largest share in this market was held by endoscopes segment in 2020. This segment has been further classified into cystoscope, laparoscopes, nephroscope, resectoscope, and ureteroscopes. The high market of these segments together makes endoscopes segment the segment with largest market share.
Laparoscopic surgeries have gained popularity because they are less invasive, offer low risk of surgical site infection (SSI), and technological advancements. These surgeries are expected to cost less than open cholecystectomies in the long run. The advanced autoclavable, rigid video-laparoscopes provide comfortable and natural three-dimensional (3D) perception with a wide field of view and realistic colors. It is the only 3D laparoscope with 30° image rotation. Nephroscope is an endoscope that is used for inspecting and passing instruments into the interior of the kidney. The nephroscopes with smaller size are useful for percutaneous nephroscopy (PCN) in both pediatric patients as well as adult patients. Resectoscope is a thin, tube-like instrument that is used for removing tissue from inside the body. Resectoscope has a light and a lens for viewing. In December 2020, Corinth developed the Veloxion system for treating symptoms that were related to benign prostatic hyperplasia (BPH). Veloxion system can be useful for transurethral resection of the prostate (TURP), which can treat enlarged prostate. It has been approved by US Food & Drug Administration (FDA). Veloxion includes a resectoscope with an integrated camera, along with a light source, and a complete fluid management system for TURP and transurethral removal of bladder tumour (TURBT). TURBT procedures make it possible for physicians to perform faster, safer and more cost-effective tissue resections.
According to Absolute Markets Insights report, urinary incontinence segment is estimated to witness fastest growth rate during the forecast period in the global urology surgical instruments market. However in 2020, chronic kidney disease segment held the largest market share according to this report. Highly prevalent among geriatric population, urinary incontinence often results in high costs, poor quality of life, and morbidity. The increasing adoption of urology surgical instruments for the procedure is contributed by significant growing awareness about incontinence, increase in the number of surgical procedures for urinary incontinence, rising adoption of these products for managing incontinence, and technological advancements in medical sector. Healthcare providers segment is expected to witness highest growth rate during the forecast period in the global urology surgical instruments market. Hospitals however, held the largest market share in 2020 because earlier urology diagnosis services and surgeries based on diagnosis were available only at hospitals. Hence, the hospitals were the target markets for the manufacturers of urology surgical instruments. Hospitals have been traditional sources of surgeries since the beginning medical science. Increasing investments towards enhancement of existing medical infrastructure and establishment of additional medical facilities is advancing the segment’s growth in the global market. For instance, in September 2021, in order to provide adequate medical care, a new hospital was established in Haryana, India. The objective of this new hospital is to ensure a higher level of clinical care across medical specialties including cardiology, general surgery, critical care, neurosurgery, orthopedics, pulmonology, urology, and others
AMI reports that the global urology surgical instruments market in North America region was the largest market in 2020 due to favorable reimbursement scenario, presence of key market players, government initiatives to combat prostate cancer in the USA, strong economy, increase in demand for minimally invasive urology surgeries, availability of advanced healthcare sector, presence of large patient populations with urinary disorders, and increasing investment in R&D in finding new ways of medical treatments related to urology are also boosting the market in this region. Investments are being made by hospitals to upgrade surgical rooms. Hospitals in North America, especially in USA and Canada are purchasing new urology surgical equipment. Other factors boosting the market growth in this region include high incidence rate of urological cancer, increase in the number of ambulatory surgical centers (ASCs) in the USA, high adoption of advanced technologies, rising number of urology procedures, incessant launch of technologically advanced products, substantial rise in the number of people affected by chronic kidney disorders as well as urinary disorders, and large-scale funds by governments of North American countries for improving the healthcare infrastructure. In December 2020, Fujifilm Medical Systems U.S.A., Inc. entered into a partnership with UroPartners. This partnership is meant to standardize on the Persona CT which is a computed tomography (CT) system that would accelerate UroPartners’ oncology treatment planning capabilities. The Persona CT was developed by Fujifilm in partnership with Analogic. This system offers not only advanced oncology simulation but also general radiography imaging capabilities that would focus on the patient experience.
Some key players in the global urology surgical instruments market are Boston Scientific Corporation, Conmed Corporation, Cook Medical Incorporated, Coopersurgical Inc., Fazzini Srl, Karl Storz GmbH & Co. Kg, Medtronic PLC, Olympus, Richard Wolf GmbH, Stryker Corporation, Teleflex Incorporated, and others.
Global Urology Surgical Instruments Market:
- By Instrument Type
- Endoscopes
- Cystoscopes
- Laparoscopes
- Nephroscopes
- Resectoscopes
- Ureteroscopes
- Imaging Systems & Video Hardware
- Monopolar & Bipolar Hand Instruments
- Catheters
- Probes & Retractors
- Forceps, Clamps and Hooks
- Scissors and Scoops
- Guidewire
- Access Sheath
- Ureteral Stent
- Dilators
- Surgical Instruments Sets
- Others
- By Application
- Benign Prostatic Hyperplasia
- Urinary Stone Disease
- Urinary Incontinence
- Cancer
- Chronic Kidney Disease
- Others
- By End Users
- Hospitals
- Healthcare Providers
- Others
- By Distribution Channels
- Online
- Offline
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Contact Us:
Company: Absolute Markets Insights
Email id: sales@absolutemarketsinsights.com
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com